ASO Manufacturing

ScreenToLead™ Oligos

Our ScreenToLead™ Oligos service streamlines your candidate screening process by providing tailored ASOs with rapid turnaround times.

Contact us

Predefined ASO packages
for drug discovery

Efficient screening is a key step in early drug development, helping identify the most promising antisense oligonucleotide (ASO) candidates. We offer two predefined ASO packages with carefully selected parameters, ensuring oligonucleotides with the right quality standards for efficient high-throughput screening of potential drug candidates.

 

Package Specifications
Custom-Modified ASOs
Cat# SC-STL-Full
ScreenToLead™ Oligos - 15–22-mer ASOs with partially to fully modified sequences.
Gapmer ASOs
Cat# SC-STL-GAP
ScreenToLead™ Oligos - 15-22-mer Gapmer ASOs with a maximum of 10 modifications.

Get Started

 

 

Six reasons to choose
ScreenToLead™ Oligos

tailored aso synthesis

Tailored ASO synthesis

Custom ASOs from 15 to 22 nucleotides, with a minimum delivery of 10 nmoles per ASO, scalable to larger batches.

chemistries

Chemistries & modifications

Offering LNA®, 2'O-Me, 2'O-MOE, 2’-Fluoro RNA, and full Phosphorothioate backbones, supporting stability, binding affinity, and efficacy.

high-throughput synthesis

High-throughput synthesis

Shasta synthesizers enable the simultaneous synthesis of up to 192 oligonucleotides, accelerating candidate screening.

high-throughput synthesis

Purification options

SePOP desalting is provided by default, with HPLC purification available on request for projects requiring higher purity.

quality controls

Quality
controls

Mass spectrometry and single quantification provide oligos with the appropriate quality for effective screening applications.

delivery format

Delivery
format

Delivered dried in single tubes, ensuring convenient handling and easy integration into your screening workflows.

Related oligo services